Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2017-06-26
Summary
The purpose of this study is to examine inflammatory processes in the airway of moderate to severe persistent asthmatics who have persistent bronchial hyperreactivity despite chronic administration of inhaled glucocorticoids.
Conditions
Interventions
- PROCEDURE
-
Bronchoscopic
Bronchoscopic procedure
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Mario Castro · Washington University School of Medicine
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Primary Completion
- 2009-02-28
- Completion
- 2011-02-28
Countries
- United States
Study Locations
More Related Trials
-
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
NCT02360072 ·Status: COMPLETED
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Longitudinal Observational Study of Severe Asthma
NCT01780142 ·Status: COMPLETED
-
Effect of Aerobic Training in Moderate or Severe Asthmatic Patients
NCT02033122 ·Status: UNKNOWN ·Phase: PHASE3
-
Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma
NCT04264377 ·Status: UNKNOWN
-
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 ·Status: COMPLETED
-
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
NCT07326995 ·Status: RECRUITING ·Phase: PHASE2
-
Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma
NCT03141424 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma
NCT06702462 ·Status: COMPLETED ·Phase: PHASE1
-
Inflammation and Corticosteroid Responsiveness in Severe Asthma
NCT00180661 ·Status: COMPLETED
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
NCT00606242 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
NCT00024544 ·Status: COMPLETED ·Phase: PHASE2
-
Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment
NCT02233231 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers of Irritant-Induced and Allergic Asthma
NCT02740543 ·Status: COMPLETED ·Phase: PHASE2
-
Mediator Release During Exercise-induced Bronchoconstriction
NCT03524053 ·Status: UNKNOWN ·Phase: NA
-
Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma
NCT00048022 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics
NCT00784459 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
NCT01334853 ·Status: COMPLETED
-
Early Antiinflammatory Treatment of Asthma
NCT00567463 ·Status: TERMINATED ·Phase: NA
-
Change in Airway Responsiveness After Allergen Exposure
NCT01699594 ·Status: COMPLETED ·Phase: NA
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Eosinophil Induced Remodelling in Asthma
NCT02648074 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2